05 January 2019 : Animal Research
Neuroprotective Effect of Astragalus Polysacharin on Streptozotocin (STZ)-Induced Diabetic Rats
Guyue Zhang1A, Hui Fang1A*, Yukai Li2B, Jing Xu1B, Dandan Zhang1C, Yanan Sun1D, Lei Zhou1D, He Zhang1EFDOI: 10.12659/MSM.912213
Med Sci Monit 2019; 25:135-141
Abstract
BACKGROUND: In the recent years, there has been increasing interest in traditional Chinese medicine as a neuroprotective nutrient in the management of chronic neurodegenerative disease, such as diabetic cognitive decline. Astragalus polysacharin (APS), a Chinese herb extract, is a biologically active treatment for neurodegenerative diseases. Therefore, in the present study, we investigated the neuroprotective effects of APS (20 mg/kg) on diabetes-induced memory impairments in Sprague-Dawley (SD) rats and explored its underlying mechanisms of action.
MATERIAL AND METHODS: Thirty SD rats were randomly divided into a control group (CON group, n=10), a diabetic model (DM) group (n=10), and an APS group (n=10). We administered 55 mg/kg streptozotocin (STZ, Sigma) by intraperitoneal injection to induce a diabetic model. Food and water intake, body weight, and blood fasting plasma glucose (FPG) were measured. The Morris water maze test (MWM) was used to assess learning and memory ability, and we measured levels of N-methyl-D-aspartate receptor (NMDA), calcium/calmodulin-dependent protein kinase II (CaMKII), and cAMP response element-binding protein (CREB) in the hippocampus.
RESULTS: APS (20 mg/kg) administration decreased the rats’ fasting plasma glucose (FPG) levels and body weight. APS (20 mg/kg) administration improved the cognitive performance of diabetes-induced rats in the Morris water maze test. APS (20 mg/kg) administration reduced the number of dead cells in the CA1 region of the hippocampus. Furthermore, APS (20 mg/kg) administration obviously upregulated the phosphorylation levels CREB, NMDA, and CaMK II.
CONCLUSIONS: These results suggest that APS has the neuroprotective effects, and it may be a candidate for treatment of neurodegenerative diseases such as diabetic cognitive impairment.
Keywords: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Astragalus membranaceus, CREB-Binding Protein, Diabetes Complications, mild cognitive impairment, Astragalus Plant, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Cyclic AMP Response Element-Binding Protein, Diabetes Mellitus, Experimental, Drugs, Chinese Herbal, Hippocampus, Maze Learning, Memory, Neuroprotective Agents, Plant Roots, Receptors, N-Methyl-D-Aspartate, Streptozocin
Editorial
01 September 2024 : Editorial
Editorial: Reasons for Increasing Global Concerns for the Spread of MpoxDOI: 10.12659/MSM.946343
Med Sci Monit 2024; 30:e946343
In Press
Clinical Research
Prognostic Significance of the Advanced Lung Cancer Inflammation Index in Metastatic Small Cell Lung Cancer...Med Sci Monit In Press; DOI: 10.12659/MSM.945752
Review article
Dangerous Intersection of Alcoholism and Othello Syndrome: A Comprehensive Review of Delusional Jealousy an...Med Sci Monit In Press; DOI: 10.12659/MSM.945616
Clinical Research
Intrathecal Morphine Enhances Postoperative Analgesia and Recovery in Robotic-Assisted Laparoscopic Partial...Med Sci Monit In Press; DOI: 10.12659/MSM.945595
Review article
Pharmacological Strategies in Dermatomyositis: Current Treatments and Future DirectionsMed Sci Monit In Press; DOI: 10.12659/MSM.944564
Most Viewed Current Articles
17 Jan 2024 : Review article 6,043,606
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,830,608
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 692,780
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,254
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074